Kara, O., Acar, S. and Elibol, T. 2022. The importance of intermediate-dose Valacyclovir in primary CMV prophylaxis after Allogeneic-stem cell transplantation, and the advantages of step-wise pre-emptive treatment in CMV reactivation. Medical Science and Discovery. 9, 6 (Jun. 2022), 324–333. DOI:https://doi.org/10.36472/msd.v9i6.743.